Jonathan Thomas — or J.T., as he’s known around the California Institute for Regenerative Medicine — came to the state’s stem cell research funding agency in June with a unique blend of experience. He’s a lawyer, investment banker and biologist who’s adept at maneuvering around the halls of government and the nonprofit world. He founded Saybrook Capital, an investment bank that did early-round financing in 2000 for stem cell company Advanced Cell Technology, and as the chairman of CIRM’s oversight board is responsible for overseeing an agency ultimately backed by $3 billion in state bonds.
No comments:
Post a Comment